Navigation Links
Appropriate treatment for breast cancer

According to researchers the appropriate treatment should be recommended for paitents with breast cancer in order to reduce the complications. Women who have// had breast cancer do well years after treatment, although those who have chemotherapy and tamoxifen may have reduced physical functioning. Researchers at the University of Cleavland report on one of the largest studies looking at quality of life in long-term survivors of breast cancer. They find that these women, on the whole, have excellent levels of health and social wellbeing. The women also score well on sexual desire, body image, mental health and energy levels.

The only drawback is that women who received adjuvant chemotherapy after surgery, or tamoxifen, reported sexual discomfort and vaginal dryness. It calls into question whether it's worth having chemotherapy or tamoxifen in the case of a very small - less than one centimeter in diameter - tumour. For larger tumours, these treatments have a definite survival value that would be set off against any long-term side effects.


'"/>




Page: 1

Related medicine news :

1. Testosterone Replacement Therapy Safe If Monitored Appropriately
2. Scientists Awarded Appropriately For Contribution Towards Medical Research
3. Nursing Home Residents Receive Appropriate Emergency Care Despite Poor Funds
4. Patient’s Individual Cardiologist Best Judge For Deciding Appropriate Treatment In Chronic Coronary Artery Diseas
5. Thyroid hormone treatment hastens recovery after cardiac surgery
6. Feeding channel created by malaria parasite - a new target for malaria treatments
7. Now umbilical cord helps in stroke treatment.
8. Now AIDS treatment comes dirt-cheap
9. Breast cancer treatment to be determined by gene test
10. Hemopurifier may revolutionise AIDS treatment
11. New drug helps boost cancer treatment
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... ... March 29, 2017 , ... How big is ... facilities, and who are the most active developers? , In the first ... Real Estate Insights (HREI) found that outpatient medical real estate development projects totaling ...
(Date:3/29/2017)... ... 29, 2017 , ... The assembly of synthetic DNA has ... repetitive steps and often scientists require many different versions of DNA. Therefore, this ... in a lower error rate and cost saving for reagents and consumables. , ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... The Wharton ... WG’81, and Julie Taffet Moelis, W’81, have made a $10 million gift to establish ... admission opportunity that will provide a pathway to a Wharton MBA for highly-qualified Penn ...
(Date:3/28/2017)... , ... March 28, 2017 , ... For many women, getting birth control isn’t as ... , meaning they either don’t have access to a health care facility or a pharmacy ... remote regions of the United States or for many who are faced with health or ...
(Date:3/28/2017)... ... 29, 2017 , ... The Thyroid Secret is a specialized ... The program was recently launched on March 1, and Dr. Wentz discussed varied ... , Dr. Izabella Wentz is a licensed pharmacist and a foremost thyroid specialist. ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 2017  Glenmark Pharmaceuticals, a global pharmaceutical company, ... investigational fixed-dose combination of mometasone furoate (25 mcg) ... a nasal spray being studied for the treatment ... a recently completed Phase 3 trial assessing the ... versus mometasone, olopatadine or placebo. "We ...
(Date:3/29/2017)... , March 29, 2017  Maxor National Pharmacy ... announced that it has named Leah Bailey ... all divisions of the company. With more ... the previous 8 years focused on health care, Bailey ... her tenure at Prime, Bailey advised the PBM, Specialty, ...
(Date:3/29/2017)... Varian Medical Systems (NYSE: VAR ) ... quarter of fiscal year 2017 following the close of regular ... be followed by a teleconference available to all interested parties ... to the conference call webcast will be available on the ... call and replay: ...
Breaking Medicine Technology: